← FDA DRUG APPROVALS

FDA ANDA · ANDA040039

TRIAMCINOLONE ACETONIDE

Sponsor: TARO

APPLICATION
ANDA040039
TYPE
ANDA
ORIGINAL APPROVAL
1997-11-26
LATEST ACTION
2019-11-27
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.1% · CREAM · TOPICAL

Approval history

2019-11-27Labeling · Supplement 17 · standardAP
2005-06-15Labeling · Supplement 3AP
1997-11-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →